13 - 15 November, 2018 | Hilton London Kensington, London, United Kingdom

Ales Strancar

Managing Director
BIA Separations

10:20 AM Industrial Purification Platform of Adeno Associated Virus

  • Discuss why adeno associated virus (AAV) is the leading vector of choice in the field of gene therapy.
  • Analyse the effects of shear and concentration methods in promoting stable associations between virus’, DNA and proteins
  • Examine the benefit of monolithic purification in increasing the speed of product capture, flow rates and column loading
  • Highlight an exclusively monolithic purification platform that includes three chromatographic steps and is fully scalable and effective for all AAV serotypes evaluated to date

Check out the incredible speaker line-up to see who will be joining Ales.

Download The Latest Agenda